Controlled release of hepatocyte growth factor from a bovine acellular scaffold for vocal fold reconstruction.
A bovine acellular scaffold was found to facilitate tissue remodeling in a rat model of vocal fold injury, whereas hepatocyte growth factor (HGF) has been shown to have an antiscarring effect in the larynx. This study examined the loading and release kinetics of HGF in vitro, and the potential of the acellular scaffold as a timed-release system for the delivery of HGF in vivo. Bilateral wounds were created in the posterior vocal folds of 20 rats, with HGF-loaded acellular scaffolds implanted into the wounds unilaterally, and scaffolds without HGF implanted into the contralateral vocal folds as control. The rats were humanely sacrificed after 3, 7, 30, and 90 days and their larynges were examined histologically and immunohistochemically. Expressions of key matrix proteins in the vocal fold coronal sections were quantified by digital image analysis. Results demonstrated a gradual, sustained release of HGF for at least 7 days in vitro, consistent with the detection of glycosaminoglycans inherent of the scaffold. In rat vocal folds implanted with HGF-loaded scaffolds, apparently fewer inflammatory cells were observed 3 days after surgery when compared to the control. The mean relative densities of collagen III and hyaluronic acid were significantly lower than those of the control 7 days after surgery. Scaffold implants were apparently degraded by 3 months in all animals, with no evidence of fibrosis or calcification. These data suggested that the bovine acellular scaffold could be promising for the exogenous delivery of select growth factors in vivo.
Xu
Chet C
CC
Otolaryngology-Head and Neck Surgery, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9035, USA.
Chan
Roger W
RW
Weinberger
Debra G
DG
Efune
Guy
G
Pawlowski
Karen S
KS
D000818:Animals; D002417:Cattle; D003692:Delayed-Action Preparations; D005260:Female; D005355:Fibrosis; D006025:Glycosaminoglycans / Q000737:chemistry; D017228:Hepatocyte Growth Factor / Q000737:chemistry / Q000378:metabolism*; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D007249:Inflammation; D007700:Kinetics; D007830:Larynx / Q000473:pathology; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D014827:Vocal Cords / Q000473:pathology*
D003692:Delayed-Action Preparations; D006025:Glycosaminoglycans; D017228:Hepatocyte Growth Factor